Tekedia Capital congratulates our portfolio company, Revna Biosciences, for hosting representatives from AstraZeneca at RevnaBio campus in Accra, Ghana. The visit, spearheaded by Deepak Arora, Country President – African Cluster, AstraZeneca, was an opportunity for the startup to showcase its world-class capabilities in fostering growth in the fields of precision medicine and molecular diagnostics. Thanks Dr Derrick Edem Akpalu, PhD, MSCR and team for executing the mission.
To learn more about Revnabio, go here. For Tekedia Capital, here.
-From RevnaBio LinkedIn page
Tekedia Mini-MBA edition 14 (June 3 – Sept 2, 2024) begins registrations; get massive discounts with early registration here.
Tekedia AI in Business Masterclass opens registrations here.
Join Tekedia Capital Syndicate and invest in Africa’s finest startups here.
We are delighted to announce that Revna Biosciences recently had the privilege of hosting representatives from AstraZeneca at our facility. The visit, spearheaded by Deepak Arora, Country President – African Cluster, AstraZeneca, was an opportunity to showcase how RevnaBio is addressing unmet needs and fostering growth in the fields of precision medicine and molecular diagnostics.
As a committed research and diagnostics organization, we are enthusiastic about the potential implications of these engagements, both now and in the future. Our team is steadfast in its mission to advance precision medicine in our region, and these interactions signify a substantial stride toward our goal of enhancing health outcomes in Africa.
---
Register for Tekedia Mini-MBA (Jun 3 - Sep 2, 2024), and join Prof Ndubuisi Ekekwe and our global faculty; click here.